They hypothesized that genetic variation in the nucleotide excision repair pathway genes could modulate DNA repair capacity and contribute to breast cancer risk and found an association between RAD23B and breast cancer risk, and between XPC and RAD23B and DNA repair capacity in the cases [117]. The gene discussed is XPC; the disease is breast cancer.